8 Result(s)

Chapter

Impedance and Collective Effects

As the beam intensity increases, the beam can no longer be considered as a collection of non-interacting single particles: in addition to the “single-particle phenomena”, “collective effects” become significan...

E. Metral, G. Rumolo, W. Herr in Particle Physics Reference Library (2020)

Article

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine

The aim of this randomized phase-II study was to evaluate the effect of substituting cytarabine by azacitidine in intensive induction therapy of patients with acute myeloid leukemia (AML). Patients were random...

R. F. Schlenk, D. Weber, W. Herr, G. Wulf, H. R. Salih, H. G. Derigs… in Leukemia (2019)

Article

Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial

Systemic therapy for advanced hepatocellular carcinoma (HCC) is still challenging. A biomodulatory therapy approach targeting the communicative infrastructure of HCC, including metronomic low-dose chemotherapy...

I. Walter, U. Schulz, M. Vogelhuber, K. Wiedmann, E. Endlicher… in Medical Oncology (2017)

Article

Human genome meeting 2016

O1 The metabolomics approach to autism: identification of biomarkers for early detection of autism spectrum disorder

A. K. Srivastava, Y. Wang, R. Huang, C. Skinner, T. Thompson, L. Pollard… in Human Genomics (2016)

Article

Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

M. Vogelhuber, S. Feyerabend, A. Stenzl, T. Suedhoff, M. Schulze… in Cancer Microenvironment (2015)

Article

Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

Therapeutic options for patients with castration-resistant prostate cancer (CRPC) remain limited. In a multicenter, Phase II study, 65 patients with histologically confirmed CRPC received a biomodulatory regim...

M. Vogelhuber, S. Feyerabend, A. Stenzl, T. Suedhoff, M. Schulze… in Cancer Microenvironment (2015)

Article

Inclusive Pomeron-Pomeron interactions at the CERN ISR

A. Breakstone, R. Campanini, H. B. Crawley… in Zeitschrift für Physik C Particles and Fie… (1989)

Article

Über die Methode, Radiokohlenstoff ¹⁴C quantitativ im Gaszählrohr zu messen

W. Herr in Fresenius' Zeitschrift für analytische Chemie (1951)